Ardent Health Reports Third Quarter 2026 Results
Ardent Health reported Q3 2026 results with total revenue up 3.1% YoY to $1.625B. Net income was $45M, or $0.17 per diluted share, compared to a loss of $23M in Q3 2025. Adjusted EBITDA was $138M. The company raised its 2026 adjusted EBITDA guidance. Adjusted admissions increased 2.9% YoY, while total surgeries decreased 1.9%.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise provide fresh material for traders; the stock may see short‑term buying interest.
Market read
First‑time earnings disclosure with improved metrics; relevant for healthcare sector investors.
What to watch
Potential impact of the 2023 cybersecurity incident costs on future margins.
Background
Ardent Health (NYSE: ARDT) released its third‑quarter 2026 financial results, showing revenue growth, a swing to net income, and an upward revision to its FY adjusted EBITDA guidance.
Ticker impact
Q3 2026 earnings release with revenue growth, profit swing to net income and raised FY2026 adjusted EBITDA guidance.
likely upward pressure as investors price in improved earnings and higher guidance
First report of earnings and guidance; earnings beat expectations and guidance raise are material for a mid‑cap healthcare stock.
Market effects
May lift peer healthcare REIT and hospital operators as earnings beat suggests sector resilience.
Limited to U.S. healthcare equities.
Low
Counterpoint
If guidance is overly optimistic, the stock could face downside on future earnings scrutiny.
Key entities
- CompanyArdent Health
U.S. healthcare provider listed on NYSE.



